As part of its commitment to strengthening regulatory partnerships across Africa, Gennvax held a high-level meeting with the Medicines Control Authority of Zimbabwe (MCAZ), represented by Dr. Zivanai Makoni, Head of the Evaluation and Registration Division.

Gennvax management and team held a high-level meeting with the Ministry of Health of Uganda, including Hon. Margaret Muhanga Mugisa, Minister of State for Primary Health Care, and Hon. Anifa Kawooya Bangirana, Minister of State for Health in charge of General Duties.

Gennvax is advancing its strategic partnership with Kenya’s Ministry of Health, with the completion of a Memorandum of Understanding (MOU) currently in process. This collaboration focuses on enhancing vaccine access, supporting national health priorities, and moving toward self-sufficiency in vaccine production.

Gennvax management held a high-level meeting with the Ministry of Science and Innovation of Uganda to discuss strategic collaboration in research and development.

Gennvax, Egypt’s pioneering vaccine manufacturing site, is dedicated to achieving self-sufficiency in core vaccines and contributing to Africa’s health security. In alignment with its vision to locally produce a significant share of the continent’s vaccine needs, Gennvax has embarked on its journey toward market access across Africa.